In this launch episode of our new ‘Life sciences in the spotlight’ podcast series, Dr Pamela Walker Geddes, partner and life sciences lead at Gate One, explores the critical dynamics of pharmaceutical companies’ patient engagement efforts in a shifting COVID-19 landscape. Pamela speaks to Novo Nordisk’s VP global marketing, Ozempic, Victoza and cardiovascular marketing development, Matyas Lakatos, and the global brand lead for Ozempic, Oren Yellinek. Gate One works with Novo Nordisk as a business transformation partner to support patient engagement initiatives across the business.
Dr Pamela Walker Geddespamela.walker@gateoneconsulting.com
Pamela is a life sciences value creation, strategic growth and acquisition advisory specialist focused on delivering impressive outcomes for businesses, their employees and their customers. She has a PhD in medical sciences and an executive MBA (both from the University of Oxford). Her career spans drug development, strategy and management consulting within the global healthcare and pharmaceutical arenas.
Dr Pamela Walker Geddes
At Gate One, we tackle your toughest challenges and accelerate your boldest ambitions. Our mission is to deliver meaningful change.
